BRG Borregaard

Borregaard ASA: Borregaard to participate in a convertible loan to Alginor

Borregaard ASA: Borregaard to participate in a convertible loan to Alginor

Borregaard, together with the shareholders Must Invest and Hatteland Group, will act as guarantors for a NOK 200 million convertible loan to Alginor.

The loan may be converted to new shares by the lenders. The subscription price upon exercise of the conversion right shall be NOK 10 per share, subject to adjustment for corporate actions such as share splits, reversed splits, dividends etc.

All shareholders in Alginor will be invited to participate in the convertible loan. Depending on the shareholder participation, Borregaard’s share of the loan will range from NOK 83 to 111 million, paid in two equal tranches in October 2025 and in February 2026.

The convertible loan will be supplemented by an additional uncommitted tap facility of NOK 100 million.

Furthermore, Alginor has received a commitment for a new secured loan facility totalling NOK 230 million through Haugesund Sparebank.

This combined financing solution is expected to be sufficient to complete and commission the ongoing investment in a commercial-scale demonstration plant for alginates.

For more information about Alginor and the convertible loan, please see .



Contact: 

Chief Financial Officer, Per Bjarne Lyngstad, +47 952 44 515

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.



EN
06/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioS...

 PRESS RELEASE

Borregaard ASA: Invitation to Q3 2025 announcement

Borregaard ASA: Invitation to Q3 2025 announcement 15 October 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q3 2025 results Borregaard will report third quarter 2025 results on Wednesday 22 October 2025 at 07:00 CEST. A stock exchange announcement will be made. A press release, the quarterly report and a presentation will be made available on . A presentation of the third quarter 2025 results will also be held at 08:30 CEST at ABG Sundal Collier, Ruseløkkveien 26, 8th floor, Oslo. Attendance in person is possible. The presentation can be followed live on web-TV at ...

 PRESS RELEASE

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013683730 of NOK 100,000,000. Start date: 14 October, 2025Maturity: 12 December, 2025Coupon: 4,20 %Organised by: DNB Markets Sarpsborg, 10 October 2025 Contact:Chief Financial Officer, Per Bjarne Lyngstad, This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.  

ResearchPool Subscriptions

Get the most out of your insights

Get in touch